Evaluation of SGLT-2 inhibitor treatment in type 2 diabetes patients with very high cardiovascular risk
Affiliation:
1. Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands;2. Leidsche Rijn Julius Healthcare Centers, Utrecht, the Netherlands